Funded biopharmaceutical research projects that have been completed

To date, CQDM has launched 28 calls for proposals, evaluated 800 research projects and implemented 11 funding biopharmaceutical research funding programs that are now completed. Information on our current programs.

The following outlines the biopharmaceutical research funding programs that have been completed to date: CQDM-CIHR, Explore, Focus, Focus on Neurosciences, Canada/Germany, Quebec Massachusetts, Quebec/Ontario.
Details on key facts and numbers on CQDM’s impact.

CQDM-IRSC
Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative advanced technologies, IT tools and medical devices that will facilitate research and development in the field of personalized medicine

Scope and research agenda

Large-scale projects that generate applicable results in biopharmaceutical research related to cancer, infection and immunity and neurodegeneration affecting cognition.

Targeted regions

Canada

Eligibility

Academic or hospital laboratories as well as SMEs (biotech companies and contract research companies) and NPOs

Public/private partnership

Required

Project specifics of the completed biopharmaceutical research funding programs

Selection criteria

Strong and immediate impact on the drug discovery or development process and active involvement of the private partners.

Project duration

Up to 30 months

Maximum amount

$750,000

List of projects

To date, 2 projects are underway or completed.
Click here to see the list.

EXPLORE

Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process

Scope and research agenda

Preliminary validation of innovative and forward-thinking ideas that could lead to revolutionary technologies

Targeted regions

Quebec and Ontario

Eligibility

Academic laboratories and SMEs (biotech companies and contract research companies).

Public/private partnership

Not required

Project specifics of the completed biopharmaceutical research funding programs

Selection criteria

Potential disruptive impact, uniqueness and innovation.

Project duration

Maximum 2 years

Maximum amount

$300,000

List of projects

To date, 21 projects are underway or completed.
Click here to see the list.

 

FOCUS
Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative technologies, tools and platforms to accelerate or facilitate the discovery or development of drugs in several therapeutic areas.

Scope and research agenda

Large-scale projects that generate applicable results to biopharmaceutical research.

Targeted regions

Quebec

Eligibility

Academic laboratories, NPOs and SMEs (biotech companies and contract research companies).

Public/private partnership

Encouraged

Project specifics of the completed biopharmaceutical research funding programs

Selection criteria

Scientific excellence, creativity and innovative nature, feasibility of execution, potential of application, history of the team.

Project duration

Maximum 3 years

Maximum amount

$2,000,000

List of projects

To date, 12 projects are underway or completed.
Click here to see the list.

 

FOCUS on Brain

Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process in neurosciences.

Scope and research agenda

Large-scale projects that generate applicable results to neuroscience biopharmaceutical research.

Targeted regions

Minimum of two Canadian provinces

Eligibility

Academic laboratories and SMEs (biotech companies and contract research companies).

Public/private partnership

Encouraged

Project specifics of the completed biopharmaceutical research funding programs

Selection criteria

Scientific excellence, feasibility and efficiency, strategic positioning, business opportunities and added value.

Project duration

Maximum 3 years

Maximum amount

$1,500,000

List of projects

To date, 8 projects are underway or completed.
Click here to see the list

 

Canada / Germany

Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process.

Scope and research agenda

Large-scale projects that generate applicable results to biopharmaceutical research.

Targeted regions

Canada and Germany

Eligibility

Academic laboratories and SMEs (biotech companies and contract research companies). Pharmaceutical companies (multinationals) are not eligible.

Public/private partnership

Encouraged

Project specifics of the completed biopharmaceutical research funding programs

Selection criteria

Public / private collaboration, generating clear deliverables and innovative nature.

Project duration

Minimum 2 years, maximum 3 years

Maximum amount

$1,000,000

List of projects

As of today, 1 project is ongoing or completed.
Click here to see the list.

Quebec / Massachusetts

Information on completed biopharmaceutical research funding programs.

Key objectives

State-of-the-art products or processes for life science marketing.

Scope and research agenda

Collaborative projects from competitive or precompetitive fields.

Targeted regions

Quebec and Massachusetts

Eligibility

SME

Public/private partnership

Not required

Project specifics of the completed biopharmaceutical research funding programs

Innovative and collaborative nature, potential for application and commercialization.

Public / private collaboration, generating clear deliverables and innovative nature.

Project duration

Maximum 2 years

Maximum amount

Maximum df $500,000 for the Quebec share, matched 1:1 by the Quebec company.

List of projects

To date, 1 project is underway or completed.
Click here to see the list.

Quebec / Ontario

Information on completed biopharmaceutical research funding programs.

Key objectives

Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process.

Scope and research agenda

Large-scale projects that generate applicable results for biopharmaceutical health research.

Targeted regions

Quebec and Ontario

Eligibility

Educational institutions and SMEs that plan to commercialize innovations in the region.

Public/private partnership

Encouraged

Project specifics of the completed biopharmaceutical research funding programs

Scientific excellence, creativity and innovative nature, feasibility of execution, potential of application, history of the team.

Public / private collaboration, generating clear deliverables and innovative nature.

Project duration

Maximum 3 years

Maximum amount

$900,000

List of projects

To date, 5 projects are underway or completed.
Click here to see the list.